From the
Laboratory for Systems Biology and Medicine and the ||Department of Molecular Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo 153-8904, the
Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd., Yokohama 222-8567, the ¶Graduate School of Biological Sciences, Nara Institute of Science and Technology, Ikoma 630-0101, and the **Department of Biochemistry and Molecular Biology, Faculty of Medicine, The University of Tokyo and the Japan Science and Technology Corp. (
CREST and ¶¶PRESTO), Tokyo 113-0033, Japan
Received for publication, March 19, 2003 , and in revised form, April 28, 2003.
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The expression of GPCRs in insect cells with recombinant baculovirus is a common technique (9). Sf9 cells, derived from Spodoptera frugiperda, are essentially free of endogenous GPCRs (10), providing a low background environment for ligand binding assays. Sf9 cells do endogenously contain certain classes of G proteins that couple to heterologously expressed GPCRs. However, various lines of evidence have made it clear the endogenous Gi-class G proteins exist only at low levels in Sf9 cells (11, 12). The 5-hydroxytryptamine (10, 1315), M2 muscarinic (16), D2 dopamine (17), 2A adrenergic (18), and formylmethionylleucylphenylalanine (11) receptors have been shown to increase ligand binding activity and/or GTP binding activity in Sf9 cells when co-expressed with Gi-class G proteins.
Although Sf9 cells are able to support very high expression levels of exogenous genes (19), the D2 dopamine receptor expressed in Sf9 cells is largely unglycosylated (20). In the case of the 2-adrenergic receptor and the formylmethionylleucylphenylalanine receptor, immature and incompletely glycosylated forms of these receptors in the cell membrane fraction of Sf9 cells have also been reported (11, 21, 22).
Loisel et al. (23) successfully recovered functional 2-adrenergic receptor from extracellular baculovirus particles by coinfection of
2-adrenergic receptor recombinant baculovirus with a baculovirus encoding the Pr55 Gag product of the human immunodeficiency virus type 1. In contrast with what had been expected, most of the recombinant
2-adrenergic receptor was excluded from the Gag particles and were found instead to be associated with extracellular baculovirus (BV) in a budded form. Surprisingly, the
2-adrenergic receptor expressed on the virus particles had been glycosylated and was biologically active. In addition, post-translational modifications were found upon agonist stimulation. It should be noted here that
2-adrenergic receptor is a Gs-coupling receptor (24), and Sf9 cells contain the Gs class G protein in some abundance (12).
BLT1 is known to be the high affinity receptor for leukotriene B4 (LTB4), which is found mainly in leukocytes and has been implicated in inflammatory activity (2528). BLT1 is also reported to couple to Gi- and Gq-class G proteins (29, 30) and is not involved in Gs-class G protein signaling. In a previous report, guinea pig brain membrane exhibited LTB4-specific binding (31). It is also reported that LTB4 binding to partially purified membrane fraction from porcine leukocytes was increased by reconstitution of Gi-class G proteins including Go (32), which is found in the brain and nervous system (33). Although these reports suggest that G
o mediates LTB4 signaling, the coupling of G
o with BLT1 has not been investigated intensively. To exploit extracellular baculovirus expression to test whether GPCR and G protein could be reconstituted on the BV, we studied the expression of human BLT1. The possible selectivity of BLT1 coupling with other classes of G proteins was also studied by means of this system.
![]() |
EXPERIMENTAL PROCEDURES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Recombinant Baculovirus Construction and Sf9 Cell CultureThe cDNA for human BLT1 (29) was amplified by PCR using a 5' sense primer containing the BamHI site and a 3' antisense primer containing the EcoRI site and inserted into pBlueBac4.5 and pBlueBacHis2A baculovirus expression vectors (Invitrogen). These were designated as pBB4.5-BLT1 and pBBH2A-BLT1, respectively. For pBBH2A-BLT1, the residual coding sequence between the enterokinase restriction site of the vector and the first Met of BLT1 was deleted by site-directed mutagenesis using the primers 5'-CTGTACGACGATGACGATAAGATGAACACTACATCTTCTGCAGC-3' and 5'-GCTGCAGAAGATGTAGTGTTCATCTTATCGTCATCGTCGTACAG-3', and the resulting plasmid was designated pBBH2-BLT1. Rat Gs cDNA (36) was digested with NcoI and HindIII and inserted into pBlueBacIII (Invitrogen). Rat G
i1 cDNA (37) mutated to lack an endogenous NcoI site in the coding region was digested with NcoI and HindIII and inserted into pBlueBacIII. Mouse G
11 cDNA (38) was digested with HindIII and inserted into pBlueBacIII. Rat G
12 cDNA (39) was digested with Bsu36I and BglII and treated with Klenow fragment to generate blunt ends. Baculovirus expression vector pAcYMI was digested with BamHI and treated with Klenow fragment. The blunt-end fragments of the vector were ligated with G
12 cDNA. Bovine G
1 cDNA was amplified by PCR using a 5' sense primer containing the SmaI and XhoI sites and a 3' antisense primer containing the SmaI and EcoRI sites and inserted into pAcYMI at the SmaI site. The cDNAs for human G
oA, Ga13, Ga14, or Ga16 were subcloned individually into pBlueBac4.5 at the KpnI and XbaI sites. The nucleotide sequences were verified by DNA sequencing. To generate recombinant viruses, Sf9 cells were co-transfected with the vector for either the BLT1, G
oA, Ga13, Ga14, or Ga16 and Bac-N-Blue viral DNA (Invitrogen). Other vectors for the G protein subunits were cotransfected individually with BaculoGold viral DNA (BD Biosciences). All viruses were produced by homologous recombination in Sf9 cells. The recombinant baculoviruses thus obtained were plaque-purified and amplified. Sf9 cells were cultured in Grace's supplemented media (Invitrogen) containing 10% fetal calf serum, 0.1% Pluronic F-68 (Invitrogen), 100 international unit/ml penicillin and 100 µg/ml streptomycin in a 1-liter spinner flask at 27 °C. Cells (2 x 106 cells/ml) were infected with the recombinant baculovirus at a multiplicity of infection of 5 for 72120 h. For production of the BV of baculovirus co-expressing receptor and G proteins, Sf9 cells (2 x 106 cells/ml) were co-infected with recombinant baculoviruses at a multiplicity of infection of 2 for each virus and harvested 72 h after infection.
Viral Particle PreparationThe BV of baculovirus was isolated basically according to the method of Loisel et al. (23). All procedures were carried out at 04 °C unless stated otherwise. The culture medium of Sf9 cells infected with recombinant baculovirus was centrifuged at 1,000 x g for 15 min to separate cells. Then the supernatant was centrifuged at 40,000 x g for 30 min. The pellet was resuspended in phosphate-buffered saline and centrifuged at 1,000 x g for 15 min to eliminate possible contamination with cell debris. The supernatant was again centrifuged at 40,000 x g for 30 min. The precipitates, used as BV fractions, were resuspended in phosphate-buffered saline or assay buffer and stored at 4 °C until use.
For preparation of the membrane fraction, the cells were resuspended in HE/PI buffer (20 mM HEPES, pH 7.4, 2 mM EDTA, 10 µg/ml leupeptin, 0.1 mM phenylmethylsulfonyl fluoride) (40). Cells were broken open by a path made with a 26-gauge needle inserted 15 times. The homogenates were centrifuged at 1,000 x g for 5 min, and the supernatants were further centrifuged at 20,000 x g for 30 min. The precipitates (the membrane fractions) were suspended in HE/PI buffer and stored at 20 °C until use.
Sucrose Density Gradient SedimentationFractionation of the BV fraction by sucrose density gradient sedimentation was performed as described by Loisel et al. (23). Briefly, 600 µg of the BV fraction, which had been suspended in 1.2 ml of TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.4) was layered onto 36 ml of a linear 2556% (w/v) sucrose gradient in TE buffer. The sample was centrifuged at 10,000 x g for 90 min. Fractions of 1.5 ml were collected from the top of the tube. Then each fraction was centrifuged at 20,000 x g for 45 min. The precipitates were resuspended with phosphate-buffered saline and used for Western blot analysis.
Electrophoresis and ImmunoblottingSDS-PAGE was carried out as described by Laemmli (41), except that samples were not heat-treated so as to minimize aggregation. For immunoblotting, proteins expressed on BV were resolved by SDS-PAGE and transferred to Hybond ECL nitrocellulose membranes (Amersham Biosciences) electrophoretically at 20 V overnight. Membranes were incubated for 1 h with Block Ace (Snow Brand Milk Products, Japan) at room temperature. Membranes were then incubated overnight at 4 °C with the primary antibody in Tris-buffered saline (TBS; 137 mM NaCl, 3 mM KCl, 25 mM Tris-HCl, pH 7.4). The following antibodies were used: monoclonal mouse anti-baculoviral glycoprotein gp64 (established in our laboratory); monoclonal mouse anti-polyhistidine (Sigma); polyclonal rabbit anti-Gs (K-20 sc-823), anti-G
oA (K-20 sc-387), anti-G
11 (D-17 sc-394), anti-G
12 (S-20 sc-409), anti-G
(T-20 sc-378), anti-G
2 (A-16 sc-374), and polyclonal goat anti-G
16 (C-18 sc-7415) (Santa Cruz Biotechnology, Santa Cruz, CA); polyclonal rabbit anti-G
i (AS/7, PerkinElmer Life Sciences); anti-G
13 (3A-190, Gramsch Laboratories, Schwabhausen, Germany); anti-G
14 (3A-195, Gramsch Laboratories). Membranes were washed 4 times with TBS with 0.05% Tween 20 and then incubated for 1 h with horseradish peroxidase-conjugated anti-mouse IgG, anti-rabbit IgG, or anti-goat IgG as the secondary antibody. Membranes were then washed 3 times with TBS with 0.05% Tween 20 and incubated with SuperSignal West Dura substrate (Pierce). Membranes were then exposed to x-ray film RX-U (Fuji Photo Film, Tokyo, Japan).
Enzyme-linked Immunosorbent AssayThe BV or membrane fractions were adsorbed to the wells of a 96-well enzyme-linked immunosorbent assay (ELISA) plate (Asahi Techno Glass, Tokyo, Japan) overnight at 4 °C. Wells were washed and blocked with TBS, pH 7.4, containing 40% Block Ace for 1 h at room temperature. After incubation with mouse monoclonal anti-polyhistidine antibody for at least 1 h, wells were washed 3 times with TBS with 0.05% Tween 20. The anti-polyhistidine antibody bound to wells was detected with the horseradish peroxidase-conjugated goat anti-mouse immunoglobulin antibody followed by the addition of substrate (tetramethylbenzidine). The reaction was terminated by acid, and absorbances at 450 nm were quantitated using a 96-well plate reader.
Ligand Binding AssayThe radiolabeled ligand binding assay was carried out in a total of 200 µl of binding buffer (50 mM Tris-HCl pH 7.4, 10 mM MgCl2, 10 mM NaCl, 0.1% fatty acid-free bovine serum albumin) (29, 42) containing the BV fraction and [3H]LTB4. To test the effect of Gpp(NH)p on [3H]LTB4 binding to the BV fractions, 0.02% (w/v) of saponin was added in the binding buffer with various amounts of Gpp(NH)p. The assay mixtures were incubated at room temperature for 1 h. The incubation was terminated by filtration of the assay mixtures through GF/C glass fiber filters (PerkinElmer Life Sciences). The filters were washed with 2 ml of ice-cold binding buffer and dried, and the remaining radioactivity was measured in a Top-count microplate scintillation counter (PerkinElmer Life Sciences). The data were analyzed with the program GraphPad Prism (GraphPad Software, San Diego, CA).
Receptor-promoted [35S]GTPS Binding AssayThe BV fractions (3 µg each) were resuspended in assay buffer (20 mM HEPES, pH 7.4, 100 mM NaCl, 10 mM MgCl2) (43) supplemented with 0.1 mM dithiothreitol, 0.1% (w/v) fatty acid-free bovine serum albumin, and 0.02% (w/v) saponin. BV fractions were incubated with GDP and 0.3 nM [35S]GTP
S with or without 100 nM LTB4 at room temperature for 1 h. The incubation was terminated by rapid filtration through GF/C filters (PerkinElmer Life Sciences). The filters were then washed with
2 ml of ice-cold assay buffer and dried, and the remaining radioactivity was measured in a Top-count microplate scintillation counter (PerkinElmer Life Sciences).
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
To clarify whether BLT1 is expressed on virus or cell debris, the BV fraction from the culture medium of Sf9 cells infected with BLT1 recombinant baculovirus was analyzed by ultracentrifugation in sucrose density gradients. As shown in Fig. 2, His-BLT1 was found to cosediment with baculovirus glycoprotein gp64. The expression time course and properties of the sedimentation of BLT1 in culture supernatant are compatible with previously reported 2-adrenergic receptor expression on extracellular budded virus (23). Thus, BLT1 is likewise deduced in this case to be expressed on the budded baculovirus. The affinity for the [3H]LTB4 of BLT1 expressed on BV seems to be low (Kd = 3.67 nM, Table I) compared with that of the membrane fraction of Cos-7 cells expressing BLT1 (Kd = 0.17 nM) (29). This is considered to be due to the low level of the Gi-class G protein in Sf9 cells, which is needed to couple to BLT1 for high affinity binding.
|
|
Reconstitution of BLT1-G Protein Coupling on Budded Virus
Expression of Receptor and Heterotrimeric G ProteinTo check for BLT1-G protein coupling on BV, we prepared recombinant baculoviruses containing the cDNAs encoding the His-BLT1 as well as the G protein i1,
1, and
2 subunits. His-BLT1 and the G protein subunits G
i1, G
1, and G
2 were expressed on BV in various combinations. After 72 h of infection, each BV fraction was collected. The amount of expressed receptor or each subunit of G protein was assessed by Western blotting (Fig. 3). When the sample was heat-treated for SDS-PAGE, BLT1 stacked in the stacking gel and did not enter the separating gel. Therefore, we performed SDS-PAGE analysis without heat treatment. For BLT1, the deduced molecular mass from the amino acid sequence is 37.6 kDa. Using anti-His antibody immunoblotting, three bands, with apparent molecular masses of 36.6, 35.5, and 34.8 kDa, were detected in His-BLT1-expressing BV. We did not observed the bands corresponding to the dimmers of the BLT1 in this system even in the presence of G protein. The amount of receptor expression decreased with co-infection of various G protein subunits in both the membrane and BV fractions (Fig. 3a). This observation was corroborated with ELISA measurement using an anti-His antibody (Fig. 4). No immunoreactive band was detected with anti-His antibody in the wild type BV sample. Each G protein subunit expressed an apparently similar amount on BV.
|
|
Ligand Binding Assay of Reconstituted Receptor and G ProteinThe BV fractions recovered from culture medium 72 h after infection with His-BLT1 recombinant virus displayed a dose-dependent binding for [3H]LTB4 (Fig. 5, a and b). In Scatchard plot analysis, the binding properties of [3H]LTB4 to BLT1 expressed on BV or membrane fractions contain both high and low affinity sites (Fig. 5, c and d). The Kd and Bmax values calculated from the Scatchard plot are shown in Table I. As shown in Table I, the ligand binding properties were similar in the Sf9 membrane and BV fractions expressing the receptor alone. For BV-expressed BLT1, the mean Kd and Bmax values of the high affinity binding sites were 0.13 nM and 0.64 pmol/mg of protein, and those of the low affinity sites were 3.67 nM and 27.3 pmol/mg of protein, respectively (n = 4). The His hexapeptide fused to the N terminus of the BLT1 did not affect ligand binding (data not shown). There was no significant specific [3H]LTB4 binding in the BV fraction prepared from the culture medium of Sf9 cells infected with the wild type baculovirus.
|
To estimate the effects of G protein on agonist affinity, the Sf9 membrane and BV fractions co-expressing receptor and G proteins were used for the [3H]LTB4 binding experiments (Fig. 5). As shown in Table I, the Bmax value of the membrane fraction co-expressing with BLT1 and Gi1 was 3.78 pmol/mg of protein, which is 2.8-fold greater than the membrane fraction expressing BLT1 alone. The co-expression of G
1
2 subunits with BLT1 also increased the high affinity site by 1.5-fold in the membrane fraction. For the BV fraction, the sample coexpressing BLT1 and G
i1 exhibited a relatively small number of high affinity binding sites (Bmax = 1.92 pmol/mg of protein). Reconstitution of the G protein heterotrimer (G
i1
1
2) switched almost all the entire receptor population to the high affinity state with a Kd value of 0.17 nM, increasing the Bmax value of the high affinity receptor 9.5-fold compared with the receptor expressed alone.
The Effect of Gpp(NH)p on Ligand Binding to BV Expressing BLT1 and G Proteins
A GTP analogue, Gpp(NH)p, which is not hydrolyzed by the GTPase activity of the G protein, was used to delineate receptor-G protein coupling. Gpp(NH)p decreased [3H]LTB4 binding to BV expressing His-BLT1 and G
i1
1
2, providing evidence for the receptor-G protein coupling (Fig. 6). On the other hand, the BLT1 BV, BLT1 with G
i1 BV, and BLT1 with G
1
2 BV were not significantly affected in ligand binding by the addition of Gpp(NH)p. These results suggest that the co-expression of the receptor and heterotrimeric G protein reconstitute to functional GPCR-G protein complex on BV.
|
The Effect of the Co-expression of Various Classes of G Protein on the [3H]Leukotriene B4 Binding Properties of BLT1 Expressed on BV
To compare the effect of the G protein subunit of various classes on ligand binding, Sf9 cells were co-infected with various combinations of recombinant baculovirus encoding several different classes of G protein subunits (
with G
1
2 in every case) and His-BLT1. Each BV fraction was collected by centrifugation, and each of the expressed proteins was detected by Western blotting (Fig. 7). The expression levels of His-BLT1 assessed by ELISA were similar among the BV fractions expressing different G proteins (data not shown). No specific signals were detected by Western blotting in the BV fraction recovered from the culture medium of Sf9 cells infected with wild type baculovirus. The ligand binding properties of these BV fractions were compared. As shown in Fig. 8, an increase of high affinity binding sites was observed in the BV co-infected with His-BLT1 and the Gi heterotrimeric G protein (G
i1
1
2). Furthermore, co-expression of Go heterotrimeric G protein with His-BLT1 (G
oA
1
2) also led to an increase in the high affinity binding sites. On the other hand, BV fractions co-expressing His-BLT1 with other classes of G protein heterotrimers (Gs, G11, G14, G16, G12, and G13) exhibited a low affinity ligand binding similar to that of BV expressing His-BLT1 alone. As shown in Table II, the Bmax value of BV co-expressing His-BLT1 and G
i1
1
2 or G
oA
1
2 in the case of the high affinity sites was similar to that of BV co-expressing other classes of heterotrimeric G proteins in the low affinity sites. These results indicate that almost all the expressed receptors in the former two BV fractions were functionally coupled to G
i1
1
2 and G
oA
1
2.
|
|
|
[35S]GTPS Binding of Heterotrimeric G Proteins Expressed in Budded Virus
To further examine the selective coupling of G proteins to BLT1, the displacement of [35S]GTPS binding by GDP in the presence or absence of 100 nM LTB4 was compared among the various BLT1 BV co-expressing different combinations of heterotrimeric G proteins (Fig. 9). Previous studies demonstrate that the agonist increases the apparent affinity of [35S]GTP
S binding sites; it also decreases the affinity of GDP binding sites (44, 45). The binding of [35S]GTP
S was greatly increased by LTB4 in BV co-expressing BLT1 and Gi or Go heterotrimeric G proteins. Displacement curves for BLT1 BV co-expressed with G
i1
1
2 or G
oA
1
2 were similar to each other both in the presence or absence of the ligand (Fig. 9, b and c). The IC50 values for the GDP of BLT1 BV co-expressing G
i1
1
2 or G
oA
1
2 were 0.25 and 0.80 µM in the absence of LTB4, and 7.58 and 12.45 µM in the presence of LTB4, respectively. These results show that BLT1 couples to Go as well as Gi heterotrimeric G proteins in BV.
|
For the BLT1 BV co-expressing Gs-class G proteins, LTB4 did not exhibit a significant effect on the displacement of [35S]GTPS binding by GDP (Fig. 9a). Although the binding of [35S]GTP
S was apparently induced by LTB4 in BLT1 BV co-expressed with Gq-class heterotrimeric G proteins, the effects of LTB4 were much less than that for BLT1 BV co-expressed with Gi-class G protein (Fig. 9, df). The GDP IC50 values for [35S]GTP
S binding on BLT1 BV co-expressed with Gq-class G proteins (G
11
1
2, G
14
1
2, and G
16
1
2) were increased by 2.3-, 2.4-, and 3.1-fold, respectively, in the presence of LTB4. The BLT1 BV co-expressing G12/13-class G protein also showed a slight difference in [35S]GTP
S binding by LTB4 (Fig. 9, g and h). The IC50 values for the GDP of BLT1 BV co-expressed with G
12
1
2 and G
13
1
2 were increased by 2.3- and 2.6-fold, respectively, in the presence of LTB4.
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Sf9 cells infected with His-BLT1 baculovirus released BV on which the BLT1 receptor was expressed. The BV fraction exhibited higher ligand binding activity than the membrane fraction, whereas the membrane fraction contained an excess amount of receptor protein. These results are in good accordance with a previous report that addressed 2-adrenergic receptor expression on extracellular virus (23). Human
2-adrenergic receptor expressed on the BV of baculovirus exhibited specific ligand binding activity (23).
2-Adrenergic receptor is known to couple to the Gs class of G protein (24). Because G
s is abundantly present in Sf9 cells, the recovered baculovirus contained sufficient intrinsic Gs-class G protein such that evidence provided that the functional high affinity receptor was expressed in BV (23).
When BLT1 was expressed alone, the BV fraction exhibited a small number of high affinity and a large number of low affinity ligand binding sites. The Kd value of LTB4 to BLT1 expressed on BV in the high affinity state was 0.126 nM, which is similar to that of human BLT1 expressed in Cos-7 cells previously reported (29). The high affinity and GTP-sensitive binding sites are thought to reflect receptors coupled to G proteins, whereas the low affinity sites represent uncoupled receptors. In Sf9 cells, various G protein subtypes are expressed in different amounts depending on the class of G protein (12, 46). The small number of the high affinity binding sites observed in BV expressing BLT1 alone may represent a receptor population coupled to endogenous G proteins.
In this study, we co-infected Sf9 cells with recombinant baculoviruses containing the cDNAs for BLT1 and mammalian heterotrimeric G protein (Gi1
1
2). The G
1
2 combination used here is capable of interacting with most classes of the G protein
subunit (13, 47). In each experiment, the expression of the receptor and G protein subunits was confirmed with immunoblotting (Fig. 3). The expression level of each component in recovered BV correlated well to the amount of recombinant baculovirus used to infect cells. The majority of the receptors expressed in the membrane fraction from Sf9 cells co-infected with BLT1 and G
i1
1
2 recombinant baculoviruses exhibited high affinity ligand binding (Fig. 5, a and c). In the membrane fraction, co-expression of BLT1 and G
i1
1
2 increased high affinity ligand binding sites 3.6-fold compared with BLT1 alone. Even co-expression of BLT1 with G
i1 alone led to a 2.8-fold increase in the high affinity binding sites compared with that of BLT1 by itself (Fig. 5c, Table I). Because G
subunits have been reported to be detected in Sf9 cells (46), the endogenous G
subunits of Sf9 cells could well be recruited to the membrane fraction co-expressing receptor and the G
subunit and could reconstitute the heterotrimer with exogenous G
i1. The BV released from the co-infected cells also exhibited high affinity for ligand binding comparable with the binding affinity observed in mammalian expression systems (29) (Fig. 5, b and d). For the BV fraction, co-expression of BLT1 and G
i1 without G
resulted in only a slight increase in the high affinity binding sites (Fig. 5, b and d), probably because BV contains a smaller amount of the endogenous G
subunits. It was necessary for BV to express both G
i1 and G
together with BLT1 to achieve maximum binding (Fig. 5d, Table I). These results are compatible with the finding that G
complex is required for optimal receptor-G protein interaction (13, 17, 18, 47). The changes in the number of high affinity ligand binding sites on BV depend on the expression of exogenous G protein subunits. From these results, a BV co-expression system could a provide better method for the reconstitution of GPCR and G proteins because the background of the endogenous G proteins is lower than in the cell membrane fraction.
The Sf9 cell expression system has also been used to study the coupling specificity of receptors toward their cognate G proteins (14, 17). Interestingly, BLT1 BV co-expressed with GoA
1
2 as well as G
i1
1
2 exhibited high affinity ligand binding (Fig. 8) and also ligand-induced GTP
S binding (Fig. 9). These data indicate that G
oA
1
2 is able to couple to BLT1 and that ligand-induced activation of the receptor led G
oA to become a GTP-bound form. Consistent with our findings, a previous report also showed that partially purified LTB4 receptor from porcine leukocytes was able to couple with exogenous Gi-class G proteins, including G
o (32). The physiological relevance of the BLT1 signaling pathway mediating G
o remains to be elucidated. G
o is reported to be expressed only in brain and neuronal tissues (33) and mediates neurotransmitter receptor signaling. Human BLT1 mRNA expresses mainly in peripheral leukocytes and also in spleen and thymus, albeit at low levels (29). Recently, BLT1 expression was reported in C6 astroglioma cells (48). A specific antagonist for BLT1 markedly inhibited
-amyloid-induced generation of reactive oxygen in C6 cells (48). BLT1 expression was also detected in the hippocampus of brain and other tissues in a GeneChip analysis of normal human tissues (System Biology and Medicine Data base, LSBM, RCAST, The University of Tokyo, www2.genome.rcast.u-tokyo.ac.jp data base). These observations are suggestive of a physiological function for BLT1 in the central nervous system.
The co-expression of BLT1 with any one of the other G proteins tested (Gs, G
11, G
14, G
16, G
12, and G
13 with G
1
2 in every case) had no significant effect on ligand binding (Fig. 8). A previous report showed the G
s did not couple to BLT1 in the cAMP response (29). The G
16, but not G
11, was considered to be coupled to BLT1 in inositol phosphate production (30). For the BLT1 BV co-expressing heterotrimeric Gq-class G protein, we observed a slight difference in the displacement of [35S]GTP
S binding by GDP in the presence or absence of ligand (Fig. 9, df). The rank order of ligand-induced [35S]GTP
S binding was G
16 > G
14 ≥ G
11, which was comparable with the previous report (30). For the G12/13-class G protein, it is speculated that G
13 also mediates BLT1 signaling functions such as chemotactic attraction of peripheral leukocytes. Although G
12 and G
13 belong to the same class of G proteins, they mediate different signals and generate overlapping effects (5). G
13 has been reported to directly interact with and activate p115 RhoGEF, a guanine nucleotide exchange factor for the GTPase Rho, which activates Rho signaling (49, 50). G
13-mediated Rho signaling regulates a variety of cellular responses such as chemotaxis, cell-cycle progression, and axonal guidance by controlling the organization of the actin cytoskeleton (51). In our findings presented here, BLT1 BV coexpressing G
13, rather than G
12, with G
1
2 exhibited slightly increased [35S]GTP
S binding by LTB4 (Fig. 9, g and h). Taken together, our data demonstrate that BLT1 expressed on BV conserve the specificity of receptor-G protein coupling seen under physiological conditions. This strongly suggests this expression system should prove highly useful for the combinatorial assessment of coupling specificity of newly identified receptors to various classes of G
subunits.
Recently, the chemokine receptors CCR5 and CXCR4 were reported to have incorporated into murine leukemia virus particles. Murine leukemia virus particles containing chemokine receptors were attached to an optical biosensor and were utilized in antibody and human immunodeficiency virus-1 gp120 binding studies (52). Furthermore, it was possible to immobilize the baculovirus BV on a matrix slide with a density of 1000 spots/cm2,2 a technological advance that led to the development of the virus chip. In a baculovirus expression system, the GPCR expressed on BV remain active for at least several months at 4 °C (data not shown), except in those rare cases of degradative inactivation. This system is considered to have several advantages over the other available expression systems in terms of application of a biochip sensor. These advantages include the availability of recombinant viruses encoding various G protein subclasses, the reconstitution of high affinity receptors by co-infection of each recombinant virus, as demonstrated here, and the low background of the intrinsic GPCR in Sf9 cells. This system is also expected to be of considerable utility in efforts to characterize the interaction of GPCR and G proteins as well as other molecules, such as the regulator of G protein signaling.
![]() |
FOOTNOTES |
---|
|||| To whom correspondence should be addressed: Dept. of Molecular Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Komaba, Meguro-ku, Tokyo 153-8904, Japan. Tel.: 81-3-5452-5231; Fax: 81-3-5452-5232; E-mail: hamakubo{at}med.rcast.u-tokyo.ac.jp.
1 The abbreviations used are: GPCR, guanine nucleotide-binding protein (G protein)-coupled receptor; G, G protein
-subunit; G
1
2, G protein
1
2 dimer; Kd, agonist dissociation constant; Ki, agonist inhibition constant; Bmax, relative maximum binding; GTP
S, guanosine 5'-3-O-(thio)triphosphate; Gpp(NH)p, guanosine-5'-(
,
-imido)triphosphate; Sf9, S. frugiperda 9; LTB4, leukotriene B4 (5(S),12(R)-dihydroxy-6,14-cis-8,10-trans-eicosatetraenoic acid); BLT1, leukotriene B4 receptor type 1; His-BLT1, His-tagged BLT1; BV, budded virus; TBS, Trisbuffered saline; ELISA, enzyme-linked immunosorbent assay.
2 T. Hamakubo, K. Dill, K. Schwarzkopf, M. Gray, K. Masuda, and T. Kodama, unpublished data.
![]() |
ACKNOWLEDGMENTS |
---|
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|